Guangdong Provincial Food and Drug Administration released the results of random inspections of drugs for 4 varieties and 4 batches that did not meet the requirements

On October 12, the Guangdong Provincial Food and Drug Administration issued the 8th phase of the 2021 drug random inspection information: 1797 batches of 861 varieties were tested to meet the drug standard requirements, and 4 batches of 4 varieties including loofah and Pudilan anti-inflammatory tablets were tested.

The original text is as follows:

Guangdong Provincial Drug Administration

notice

No.

In order to strengthen the supervision of drug quality and ensure the safety of drug use by the public, according to the 2021 Guangdong Drug Sampling Inspection Plan, the Guangdong Drug Supervision and Administration Bureau organized random drug quality inspections on drug production and operation enterprises and medical institutions across the province

1.

Recently, a total of 1801 batches of 861 drugs from 74 drug manufacturers, 449 drug distributors and 167 medical institutions have been sampled across the province

After verification and confirmation, the current sampling information is announced as follows: 1797 batches of 861 varieties have been inspected to meet the drug standards

2.

The Guangdong Provincial Drug Administration requires relevant enterprises and units to take risk control measures such as suspension of sales and use, recalls, etc.

3.

The Guangdong Provincial Drug Administration reminds consumers to purchase drugs from legal and formal medical institutions, pharmacies, etc.